nd euro congress on cancer science & therapy...viral mimicry of genes research and analytical...

Cancer Science & TherapyMarch 07-08, 2019

Barcelona, Spain

32nd Euro Congress on

S C I E N T I F I C P R O G R A M

conferenceseries.com

SCIENTIFIC PROGRAMDAY 1

Thursday, 07th March

08:30-09:00 Registrations

09:00-09:30 Introduction

09:30-09:50 COFFEE BREAK

09:50-11:50 Meeting Hall 01

KEYNOTE LECTURES

MEETING HALL 01 MEETING HALL 02

11:50-13:10 Talks On: Cancer Science

Talks On: Cancer Therapy

Tumour progression Chemotherapy

Tumour immunology Molecular targeted therapies

Carcinogenesis & Mutagenesis Hormone replacement therapy

Organ defined cancers Stem cell therapy

13:10-13:15 GROUP PHOTO

13:15-14:00 LUNCH BREAK


14:00-16:00 Talks On: Cancer Diagnosis and Screening Talks On: Cancer Metabolomics

Screening test Metabolic pathways

Biopsy Tumour cell proliferation

Sigmoidoscopy Oncogenomics

Nuclear imaging Metabolomics as biomarker

Molecular diagnosis and diagnostics Cancer Genome Atlas(TCGA)


MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)

Young Researchers in Cancer Science and Therapy

Workshop

Visit: https://cancerscience.insightconferences.com/

SCIENTIFIC PROGRAMDAY 2

Friday, 08th March

09:00-10:30 Meeting Hall 01

KEYNOTE LECTURES



10:50-12:50 Talks On: Cancer Nanotechnology and Tumor Virology

Talks On: Cancer Pharmacology

Active tumor targeting Cancer drug targets

Nanoparticle packages Clinical trials and drug discovery

Laser ablation Anticancer therapeutics

Viral-associated Cancers Preclinical models for drug evaluation

Viral mimicry of genes Research and analytical methods

Viral therapy Cancer vaccines

12:50-13:35 LUNCH BREAK


13:35-15:55 Talks On: Cancer Therapeutics and NovelApproaches

Talks On: Cancer Case Reports

Cancer epigenetics Unexpected/Unusual conditions

Molecular profiling techniques Rare surgical condition of a cancer case

New biologics & vaccines Novel surgical procedure

Immuno-oncology biomarkers and companion Adverse effects

Novel biomarker discovery cancer therapy database


MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)

Poster Presentations Workshop

Awards & Closing Ceremony


32nd Euro Congress on Cancer Science

& Therapy

MARCH 07-08, 2019 | BARCELONA, SPAIN

AGENDA

SPEA

KER S

LOTS

AVAI

LABL

E

Colin Paul Spears MD is a medical oncologist-hematologist with a background in alkylating agent kinetics in collaboration with the late Prof. George Olah (Nobelist 1994, Chemistry) at the University of Southern California, where he pioneered nucleophilic selectivity assays. Dr. Spears was chair of the Cancer Center at Mercy General Hospital in Sacramento, California for 10 years, in private practice, 2006-2016, and is Professor of Hematology at California Northstate University College of Medicine near Sacramento, California.

Georgia Zhuo Chen is currently Professor of Hematology and Medical Biology in Emory University. Dr. Chen has received several awards from the US National Institutes of Health (NIH) as a PI in the study of lung and head and neck cancers in the past years. She has generated more than 160 publications in peer-reviewed journals and serves as an editorial board member for 5 journals. Dr. Chen received the NIH Career Development Award in 1998 and an award as a Georgia Cancer Coalition Distinguished Cancer Scholar in 2006.

Jia Changku is working as a Professor at Department of Hepatobiliary Pancreatic Surgery, Hangzhou First People’s Hospital, Nanjing Medical University, China

SPEA

KER S

LOTS

AVAI

LABL

E

Douglas E Gladstone is an Associate Professor in the Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a Clinical Director of the Outpatient Bone Marrow Transplant Unit. In 2017, he led an educational program discussing how to lower donor specific antibodies to permissible levels for allogeneic bone marrow transplantation at the Annual American Society of Hematology conference

Jehad Zweiri, lecturer in Cancer studies at the University of Liverpool Medical School, born and grew up in Jordan and received his Bachelor’s degree from the University of Jordan in 1990. He obtained his master degree from London School of Hygiene and Tropical Medicine/University of London, and then obtained his PhD degree in 2000 from Kings College Medical School/University of London, in the field of Immune Gene Therapy of Cancer under the supervision of Professor Farzin Farzaneh. He then started his work as Postdoctoral Associate at the department of Immunology and Medicine at the University of Liverpool in 2002. In 2010 he was appointed as a lecturer in the university of Liverpool medical school and he is currently fellow of the British Higher Education Academy since 2012.

Associate Professor Vincent Murray has been an academic at the University of NSW since 1990. Murray obtained his BSc (Hons) from Glasgow University, U.K. and his PhD from the National Institute for Medical Research, London, U.K. He carried out post-doctoral research at Princeton University, U.S.A and the Cancer Institute, Melbourne, Australia. He has been an active researcher in the field of molecular biology and cancer and his lab has concentrated on investigating the interaction of anti-tumour drugs with DNA. He has focussed his research on several cancer chemotherapeutic agents including bleomycin, cisplatin and cisplatin analogues. Murray has published over 100 peer-reviewed papers.

SPEA

KER S

LOTS

AVAI

LABL

E

A Graduate of the University of St Andrew’s in Scotland and the University of Manchester Medical School UK. Professor O’Dwyer underwent postgraduate clinical training in the North West of England and undertook a Research Fellowship in Harvard University, Boston, USA. She continues to be involved in clinical research supervising research fellows for PhD and MD degrees by theses. She has over 100 publications and has delivered over ninety invited lectures. She is actively involved with the Association of Coloproctology of Great Britain and Ireland (ACPGBI) being chair of the peritoneal malignancy committee, member of the multidisciplinary clinical committee, a former council member and North West Regional Representative.

Jaime Tisnado graduated from Leoncio Prado Military Academy. He received his BM degree from San Marcos National University, College of Sciences. He received his MD degree summa cum laude from the same San Marcos National University Medical School.. He then became an Assistant Professor of Radiology and Director of Interventional Radiology at Albany Medical College, Albany, NY, 1974-77. Thereafter he moved to Virginia Commonwealth University, in Richmond, VA, where he became Associate Professor of Radiology and Director of Interventional Radiology and eventually became Professor of Radiology and Professor of Surgery, at the same university from 1985 till 2010. Thereafter, he was named one of the few Professor Emeritus of Radiology and Surgery, all at the same Virginia Common wealth University in 2010 till now.

Professor Yingbin Liu,, serves as the director of Department of General Surgery, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine. and the director of the Shanghai Research Institute of Biliary Tract Disease. In 2016, he was awarded the International Fellow of the American College of Surgeons. Professor Liu has been engaged in both clinical and basic research in the field of the hepatobiliary and pancreatic cancer since 1984. He has completed 7 projects of National Natural Science Foundation of China and more than 10 projects at provincial level or above.He has supervised more than 30 postgraduate and Ph.D. students and post-doctoral scholars in research field of stomach, liver and gallbladder cancers.

SPEA

KER S

LOTS

AVAI

LABL

E

Dr. Ashok Srivastava is Chief Executive Officer and Chief Medical Officer of Cure Pharmaceuticals, and ClinFomatrix Oncology, He has more than 15 years of experience in drug development, medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase I – 4, and marketing commercialization of Hematology, Oncology and radio pharmaceutical drugs in USA, EU and Japan. He is leader in Cancer Drug Development Worldwide large and complex Phase 3 Clinical Trials in many countries. He contributed to 21-INDs and 7-NDAs of Cancer Drugs, acquisition /merger of company and drug for more than $700 million.

Dr. Bhattacharjee did her B.Sc in Biotechnology from Bangalore University in 2006 and M.Sc in Applied Genetics from Bangalore University in 2008. She then moved to England to pursue her DPhil (Phd) in Biochemistry from Oxford University where she studied the role of Fml1 and its partner proteins Mhf1 and Mhf2 in promoting genome stability. She was awarded her DPhil in 2012. During her time at Oxford, she was also a tutor at Greene’s College, Oxford. In 2013, Dr. Bhattacharjee moved to Cold Spring Harbor Laboratory, New York. At CSHL, her work has focused on understanding the epigenetic regulation of DNA repair. She is also an academic tutor at the Watson School of Biological studies, the school for graduate studies at CSHL.

Farnaz is currently studying Medical physics in PhD degree at RMIT University. She is a Clinical medical physicist with three years of experience in radiation oncology gained in both solo and group settings. Competent to independently perform treatment planning and treatment delivery duties. Good understanding of quality assurance for linear accelerators. To practice all aspects of clinical medical physics for an accurate, safe and effective delivery of radiotherapy treatment for the cancer patients, pursuing a broad range of clinical research projects in radiotherapy. Also now she is working at university as a course coordinator and also has a teaching experience in university in subjects such as radiotherapy, Physics of MRI and CT scan.

SPEA

KER S

LOTS

AVAI

LABL

E

Graduated in Pharmaceutical Sciences from the Faculty of Imperatriz - FACIMP / Wyden (2014). She was a Fellow of CNPQ / FAPEMA and a student of scientific initiation in the pharmacognosy, microbiology and chemistry laboratories of the FACIMP / Wyden Department of Pharmaceutical Sciences. He has experience in the areas of pharmacognosy, pharmacology, pharmacobotany and microbiology, working mainly on the following topics: Identification of secondary metabolites, organography and microtechnology, production of plant extracts and analysis of antimicrobial activity, such analyzes performed with leaves and oil-resin of Copaíba (Copaifera spp.). She currently holds a master's degree in Nanoscience and Nanobiotechnology at the University of Brasília (UnB) under the guidance of Prof. Dr. João Paulo Figueiró Longo, focused on the study of vascular remodeling in breast tumors and its influence on the Enhanced Permeability and Retention (EPR) effect with the application of a mathematical model to predict hemodynamic parameters

Lorenzo Belluomini, is working as a Medical Doctor at Department of Medical Oncology, University Hospital Ferrara, Italy

Professor Yingbin Liu,, serves as the director of Department of General Surgery, Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine. and the director of the Shanghai Research Institute of Biliary Tract Disease. In 2016, he was awarded the International Fellow of the American College of Surgeons. Professor Liu has been engaged in both clinical and basic research in the field of the hepatobiliary and pancreatic cancer since 1984. He has completed 7 projects of National Natural Science Foundation of China and more than 10 projects at provincial level or above.He has supervised more than 30 postgraduate and Ph.D. students and post-doctoral scholars in research field of stomach, liver and gallbladder cancers.

SPEA

KER S

LOTS

AVAI

LABL

E

Angie Bedoya is a dentist, MSc in biochemistry, she is a Ph.D. student in biotechnology at National University of Colombia. This work belongs to her thesis topic.

Sara is currently a medical student at King Saud University, vice president of student council and co-founder of nanotechnology club at her university. Her research interests are focused on the translational research of oncology, personalized medicine, artificial intelligence, and nanotechnology.

Dr Neeraj Jain is Associate Prof Radiation Oncology At Sri Guru Ram Das University Of Health Sciences Amritsar. He is eminent Radiation Oncologist and participated in Numerous national and international conferences and presented papers. He is Vice Chairman of Indian College Of Radiation Oncologists (ICRO). ICRO is an academic wing of AROI i.e. Association Of Radiation Oncologists of India. He is well versed in modern Radiotherapy techniques.

SPEA

KER S

LOTS

AVAI

LABL

E

Lina Elsalem earned her Ph.D. in Cancer Pharmacology from The Institute of CancerTherapeutics at University of Bradford, UK. She is a young researcher and investigator in the field of Cancer Research. Currently, she is working on projects related to drug metabolizing enzymes in colorectal and bladder carcinoma as well as bacterial drug resistance in wound infections. She presented more than 10 abstracts at prestigious national and international conferences. Currently, she is an assistant professor in the department of pharmacology at faculty of Medicine/ Jordan University of Science and Technology. Her research interests are focused in the role of hypoxia in the regulation of drug metabolizing enzymes in tumour microenvironment as well as drug resistance in solid tumours and bacterial infections.

Dr. Sina Ghanean earned his Ph.D. in Oral and maxillofacial surgery at Shahid Sadoughi University of Medical Sciences, Yazd, Iran. He has published more than 7 papers in reputed journals and presented more than 8 abstracts at prestigious national and international conferences. Also, he has participated in writing/editing 5 books/chapters in the field of oral and maxillofacial surgery. Currently, his research interests are focused in discovering new methods for early diagnosis and treatment of squamous cell carcinoma.

Ibrahim Elsayed Mohammed has completed his master degree in pharmacology at the age 0f 29 years from meical research institute, Alexandria university, Egypt, and now he is finishing his phD in pharmacology from Cairo university, Egypt. He is an assistant lecturer of pharmacology and toxicology at pharos university in Alexandria. He has published 4 papers in reputed journals(research journal of oncology , LIFE SCIENCES, journal of medical oncology, and journal of medical research institute.

SPEA

KER S

LOTS

AVAI

LABL

E

Magda Mohamed Sultan has completed her MD in clinical pathology and laboratory oncology from National Cancer Institute Cairo University.(1992) She was the Head of the hematology department of Medical Researh Institute .Alexandria University .Egypt for 8 Years (2007-2015) . She is now an emeritus professor in the institue , sharing in teaching for doctor and master degrees and she is the head of hematology department of Alborg LaB in alexandria since 1996 till now . She has published more than 25 papers and she is arbitrator for many thesis and many published papers.

Ahmed Malki is working as an associate professor of Biomedical Sciences College of Health Sciences Qatar University

M. A. Alnafea worked, taught, and trained in many local and international hospitals as a medical imaging technologist and a medical physicist. He has completed his PhD at the age of 33 years from the university of Surry, UK and postdoctoral studies from King Saud University. He then worked as Assistance Professor then as director of Radiologic Sciences Dept. for 2 years, He then worked for two years as Vice dean for Academic affair in the College of Applied Medical Sciences. He then worked as consultant at the ministry of higher education, vice ministry for scholarship, medical education department (2011-2015). Sense June 2015 he has being working as an academic and researcher. His Current research projects supported by the National Science, Technology and Innovation Plan (NSTIP) and King Abdulaziz City for Science and Technology. He is the Principal Investigator and Project Manager and the title of the current project:” Development of a proof-of-concept demonstration system for 3D coded aperture Scintimammography”.

Alvaro Macieira-Coelho French National Institute of Health (INSERM), France

Liane Deligdisch Icahn School of Medicine at Mount Sinai, USA

Tatiana Massarrah Gregorio Maranon Hospital, Spain

Sherry A Bradford AccuTheranostics, Inc., USA

Aleksandar Stefanovic Clinical Center of Serbia, Serbia

Nyla A Heerema The Ohio State University Wexner Medical Center, USA

Charles L Hitchcock The Ohio State University, USA

Alice Dragomir McGill University, Canada

M Helena Vasconcelos University of Porto, Portugal

Rita Lakhani Krishna University of Health Sciences, India

Audrey Claing Montreal University, Canada

Hirendra Nath Banerjee University of North Carolina, USA

Katarina Jeremic University of Belgrade, Serbia

Vasco Fonseca Centro Hospitalar Lisboa Ocidental, Portugal

Isaura Meza CINVESTAV, Mexico

Robert Thomas Bedford and Addenbrooke’s Cambridge University Hospitals, UK

Shanmugasundaram Ganapathy Kanniappan Johns Hopkins University, USA

Qi-Fei Wang The First Affiliated Hospital of Dalian Medical University, China

Kuniaki Arai Kanazawa University Hospital, Japan

Adnan Yousif Rojeab London College UCK, UK

Wioletta Rozpędek Medical University of Lodz, Poland

M Inês Silva University of Porto, Portuga

Diana Sousa University of Porto, Portugal

Joana Pereira University of Porto, Portugal

PAST AFFILIATESPA

ST A

FFIL

IATE

S


Liyun Shi Hangzhou Normal University School of Medicine, China

Gina Marcela Méndez-Callejas University of Applied and Environmental Sciences, Colombia

Maria Isabel da G. S. Ramos University of Cape Verde, Africa

Adnan Yousif Rojeab London College UCK, UK

Robert Thomas Bedford and Addenbrooke’s Cambridge University Hospitals, UK

Sonia A Melo University of Porto, Portugal

Zofia Felicja Bielecka Warsaw Medical University, Poland

Mahmood Faraz Umea University, Sweden

Carolina F Ruivo Institute for Research and Innovation in Health, Portugal

Nuno Bastos University of Porto, Portugal

So Young Kim Chungbuk National University, South Korea

Sung S Choi Chung-Ang University College of Medicine, South Korea

Leclerc Anne-France University Hospital Centre of Liege, Belgium

Mahmood Faraz Umea University, Sweden

Madiha Nazir Uppsala University, Sweden

Fouad Azizi Hamad Medical Corporation, Qatar

Andrés Julián Gutiérrez-Escobar University of Applied and Environmental Sciences, Colombia

Purusottam Mohapatra Lund University, Sweden

Messafeur Abdelkrim University Sidi Bel Abbes, Algeria

Sanjay Gandhi Southmead Hospital, UK

PAST AFFILIATESPA

ST A

FFIL

IATE

S


Vikas Leelavati Balasaheb Jadhav Dr.D.Y.Patil University, India

Abdulrahman A. S. Alsayyari Qassim University, Saudi Arabia

Masoud Hashemi Shahid Beheshti University of Medical Sciences, Iran

Hissa Mohammed National center for Cancer Care and Research, Qatar

Chih-Jen Hung Taichung Veterans General Hospital, Taiwan

M. A. Alnafea King Saud University, Saudi Arabia

Monica Kansal Jaypee Hospital, India

David Sipos University of Pecs Faculty of Health Sciences, Hungary

Amjed Eljaili Ysbyty Gwynedd, UK

Shahriari Mozhgan Tehran University, Iran

Daniel L. Farkas University of Southern California, USA

Claudia Paola Rivera-Uribe Nuevo León Autonomous University, Mexico

Ala khasawneh University of Pécs, Hungary

Syed Muhammad Anwar University of Engineering and Technology, Pakistan

Kunwarpal singh Sri Guru Ram Das Institute of Medical Sciences and Research, India

Shajeem Shahudeen Vivid Diagnostic Centre, India

Dongyeon Lee Yonsei University, South Korea

M. A. Alnafea King Saud University, Saudi Arabia

David Sipos University of Pecs Faculty of Health Sciences, Hungary

Ala khasawneh University of Pécs, Hungary

Mustafa Sabil United Kingdom

PAST AFFILIATESPA

ST A

FFIL

IATE

S


Zang-Hee Cho Seoul National University, South Korea

Bin Zheng University of Oklahoma, USA

Michael L Goris Stanford University School of Medicine, USA

Bital Savir-Baruch Loyola University Medical Center, USA

Ilona Kowalik-Urbaniak Client Outlook Inc., Canada

Monika Beresova University of Debrecen, Hungary

Hang Joon Jo Mayo Clinic, USA

Elaine Iuanow Cleveland Clinic Foundation, USA

Barath Narayanan Narayanan University of Dayton, USA

Jamal Zweit Virginia Commonwealth University, USA

David A Gutman Emory University School of Medicine, USA

Limin Yang University of Iowa, USA

Tamara Feygin University of Pennsylvania, USA

Hesham El Sheikh Benha University, Egypt

Manohar Roda University of Mississippi, USA

Daniel Pastore Sao Paulo University School of Medicine, Brazil

Mafalda Gomes University of Porto, Portugal

Nilda Espinola-Zavaleta National Institute of Cardiology Ignacio Chavez, Mexico

Svjetlana Jefic University Clinical Centre of Repablic of Srpska, Bosnia and Herzegovina

Aminur Rahman National Institute of Neurosciences and Hospital, Bangladesh

Shivaram Poigai Arunachalam Mayo Clinic, USA

PAST AFFILIATESPA

ST A

FFIL

IATE

S


Glimpses of Cancer Conferences

Barcelona Attractions

Cam

p Nou

Sta

dium

Tibidabo

Barrio

Got

ico

Park

Gue

ll

Pica

sso

Mus

eum

Las S

agra

da Fam

ilia

Mon

tjuïc

Castl

e

Cass

a Bat

llo

La B

arce

lone

ta

nd euro congress on cancer science & therapy...viral mimicry of genes research and analytical...

Documents